Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-006179-20Phase 4Active
Phase 4, randomised trial of insulin glulisine, insulin glargine and human insulin in hyperglycemia (2 arms), sponsored by Endocrinology and Nutrition Unit. Primary endpoints: Patients with at least one hypoglycemia episode and Hypoglycemia rate per day. Started Oct 2012; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-006179-20.